Gerresheimer AG Plans Sale of Moulded Glass Business

Gerresheimer AG has decided to separate its moulded glass business following the completion of a strategic review. The company intends to proceed with a sales process for this division. This decision is in line with Gerresheimer's strategy to transform into a pure system and solution provider for the pharmaceutical and biotech industries.

In 2024, Gerresheimer explored the best growth opportunities for the moulded glass segment. The move to divest reflects the company's focus on a specialized portfolio in primary packaging and drug delivery systems. This shift aligns with Gerresheimer's aim to enhance its competitiveness and growth within its core industries.